Ramesh Kumar
Direktor/Vorstandsmitglied bei OCUGEN, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Ramesh Kumar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OCUGEN, INC. | Independent Dir/Board Member | 27.09.2019 | - |
| Direktor/Vorstandsmitglied | 27.09.2019 | - | |
| Comptroller/Controller/Auditor | - | 15.09.2023 | |
| Ocugen OpCo, Inc. | Direktor/Vorstandsmitglied | 01.06.2019 | - |
Karriereverlauf von Ramesh Kumar
Ehemalige bekannte Positionen von Ramesh Kumar
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRAWS PHARMA, INC. | Direktor/Vorstandsmitglied | 29.04.2011 | 15.01.2019 |
| Vorstandsvorsitzender | 22.12.1998 | 15.01.2019 | |
| Gründer | 22.12.1998 | 15.01.2019 | |
| Präsident | 22.12.1998 | 21.06.2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Direktor/Vorstandsmitglied | - | - |
| Kimeragen, Inc. | Corporate Officer/Principal | - | - |
| Princeton University | Corporate Officer/Principal | - | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Ausbildung von Ramesh Kumar
| University of Illinois | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
| Indien | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Kimeragen, Inc. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Ocugen OpCo, Inc. |
- Börse
- Insiders
- Ramesh Kumar
- Erfahrung
